KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

CareDx (CDNA) Income from Continuing Operations (2016 - 2026)

CareDx's Income from Continuing Operations history spans 14 years, with the latest figure at 2809000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 127.13% to 2809000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 8192000.0, a 113.2% decrease, with the full-year FY2025 number at 21354000.0, down 140.64% from a year prior.
  • Income from Continuing Operations hit 2809000.0 in Q1 2026 for CareDx, up from 4108000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for CDNA hit a ceiling of 87697000.0 in Q4 2024 and a floor of 118097000.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 13700529.41 across 5 years, with a median of 16972000.0 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 2759.97% in 2022 and later skyrocketed 174.26% in 2024.
  • Tracing CDNA's Income from Continuing Operations over 5 years: stood at 18329000.0 in 2022, then crashed by 544.32% to 118097000.0 in 2023, then skyrocketed by 174.26% to 87697000.0 in 2024, then crashed by 104.68% to 4108000.0 in 2025, then soared by 168.38% to 2809000.0 in 2026.
  • Business Quant data shows Income from Continuing Operations for CDNA at 2809000.0 in Q1 2026, 4108000.0 in Q4 2025, and 1675000.0 in Q3 2025.